HeartRhythm

APRIL 30, 2024

Hypertrophic cardiomyopathy (HCM) has a prevalence of 1 in 500 people and highly increases the risk of sudden cardiac death (SCD). Diagnosis is typically based on the Echocardiogram, while cardiac MRI is used for detection of myocardial scarring through Late Gadolinium Enhancement (LGE), an important risk marker for SCD.

Sudden Cardiac Death 40

Sudden Cardiac Death Cardiomyopathy Electrocardiogram Echocardiogram 40

Circulation

NOVEMBER 11, 2024

Shortly thereafter, a cardiac MRI was significant for probable HOCM based on septal hypertrophy, late gadolinium enhancement (LGE) with mid-wall fibrosis in the basal/mid inferolateral segments, and systolic anterior motion (SAM) of the mitral valve. Pre-stress echocardiogram revealed a sigmoid septum with septal wall thickness of 1.6

Cardiomyopathy 40

Cardiomyopathy Sudden Cardiac Death Echocardiogram Bicuspid/Mitral 40

Open Heart

APRIL 20, 2022

Objectives To describe a cohort of patients with arrhythmogenic left ventricular cardiomyopathy (ALVC), focusing on the spectrum of the clinical presentations. Twenty-one (41%) had normal echocardiogram, 13 (25%) a hypokinetic non-dilated cardiomyopathy (HNDC) and 17 (33%) a dilated cardiomyopathy (DCM).

Cardiomyopathy 52

Cardiomyopathy Chest Pain Sudden Cardiac Death Heart Failure 52

Circulation

NOVEMBER 11, 2024

CS has a range of clinical syndromes: impaired conduction, arrhythmias, heart failure, and sudden cardiac death. A cardiac monitor revealed intermittent 2-1 AV block and high degree AV block occurring mostly during sleep. An echocardiogram revealed normal biventricular function and morphology. cm in size.

Sudden Cardiac Death 40

Sudden Cardiac Death Heart Failure Echocardiogram Pacemaker 40

Heart BMJ

NOVEMBER 27, 2023

Methods The Outcomes Registry for Cardiac Conditions in Athletes was a nationwide prospective multicentre observational cohort study that captured testing and outcomes data from 45 institutions (September 2020–June 2021). Athletes with an ECG and transthoracic echocardiogram (TTE) and no pre-existing conditions were included.

COVID-19 52

COVID-19 Sudden Cardiac Death Aortic Atrial Fibrillation 52

BoardVitals - Cardiovascular

MAY 1, 2017

Whether you’re gearing up for your Family Medicine or Cardiology Board Exam, you’ll need to master the topic of Hypertrophic Cardiomyopathy (HCM). Echocardiogram is indicated (Correct) C. Start aspirin and Plavix Correct answer: (B) (B) Echocardiogram is indicated. Hypertrophic cardiomyopathy is one of them.

Cardiomyopathy 52

Cardiomyopathy Sudden Cardiac Death Bicuspid/Mitral Electrocardiogram 52

Open Heart

AUGUST 25, 2023

Background Consensus guidelines support the use of implanted cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death in patients with either non-ischaemic or ischaemic cardiomyopathy with left ventricular ejection fraction (LVEF) ≤35%. vs 65.4%, p<0.0001), more often white (87.5%

Defibrillator 52

Defibrillator Sudden Cardiac Death Myocardial Infarction Echocardiogram 52